Mirum Pharmaceuticals MIRM 深 沪
等待开盘 09-19 09:30:00 美东时间
75.32
+2.180
+2.98%
华盛通- 最 高75.34
- 今 开73.04
- 成交量 69.40万股
- 最 低 72.50
- 昨 收 73.14
- 总市值 37.84亿
- 52周最高 78.095
- 市盈率 静 --
- 换手率 1.38%
- 52周最低 36.8801
- 委 比 -99.40%
- 总股本 5023.76万
- 历史最高 78.095
- 量 比 1.52
- 振 幅 3.88%
- 历史最低 6.513
- 每 手 1
- 风险率 9.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元
09-15 11:13
Demystifying Mirum Pharmaceuticals: Insights From 6 Analyst Reviews
Providing a diverse range of perspectives from bullish to bearish, 6 analysts h...
09-12 21:01
JP Morgan Maintains Overweight on Mirum Pharmaceuticals, Raises Price Target to $77
JP Morgan analyst Jessica Fye maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and raises the price target from $53 to $77.
09-12 19:16
Stifel Reinstates Buy on Mirum Pharmaceuticals, Announces $89 Price Target
Stifel analyst Dae Gon Ha reinstates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and announces $89 price target.
08-11 19:11
Deep Dive Into Mirum Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
In the last three months, 6 analysts have published ratings on Mirum Pharmaceut...
08-09 02:02
What to Expect from Kymera Therapeutics's Earnings
Kymera Therapeutics (NASDAQ:KYMR) is gearing up to announce its quarterly earni...
08-08 23:01
Mirium Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.
Mirium Pharmaceuticals shares are trading higher after the company reported bet...
08-07 05:00
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Recursion Pharmaceuticals Earnings Preview
Recursion Pharmaceuticals (NASDAQ:RXRX) is gearing up to announce its quarterly...
08-05 01:05
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
